LIVE WEBINAR
Tuesday, June 17th | 10:30am ET
Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording. ​

Outsourcing has taken a growing role in the clinical trial landscape, becoming more popular as drug developers lean on clinical research organizations (CROs) to address clinical trial complexity, expand their capabilities, recruit valuable talent and more. However, outsourcing is not a one-size-fits-all solution and can be employed in a variety of models to fit specific research needs.

Traditionally, the most common outsourcing arrangements are functional service provider (FSP) partnerships and full-service outsourcing (FSO). However, sponsors are increasingly adopting a hybrid outsourcing model where FSP partnerships augment FSO arrangements to maximize clinical development speed and efficiency and help biopharmaceutical and biotech companies meet their timelines. In this webinar, viewers will learn how mixed-model solutions: 

• Provide sponsors with agility and flexibility to optimize clinical trial operations 
• Address unanticipated or changing demands 
• Maximize clinical trial performance 
• Overcome persistent challenges in clinical trial operations

SPEAKERS

Lori Boyce
Vice President, PPD FSP solutions
Thermo Fisher Scientific
 

Kate Pavlik
Business Segment Lead, Functional Operations, PPD FSP solutions
Thermo Fisher Scientific